While HNF1B mutations are primarily associated with kidney disease and diabetes, it is crucial to consider the additional clinical features found more frequently in this cohort such as liver lesions, neuropsychiatric symptoms, and metabolic disturbances (hyperlipidemia, hyperuricemia, and hypomagnesemia) to fully understand the spectrum of this condition. Here, HNF1B is linked to hyperlipidemia.